Tearsheet

Quest Diagnostics (DGX)

Market Price (9/13/2025): $184.5 | Market Cap: $20.7 Bil
Sector: Health Care | Industry: Health Care Services

Quest Diagnostics (DGX)

Market Price (9/13/2025): $184.5
Market Cap: $20.7 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.3%, FCF Yield is 6.0%	Trading close to highs Dist 52W High is -0.8%, Dist 3Y High is -0.8%	Weak revenue growth Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.2%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 16%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12%	Weak multi-year price returns 3Y Excs Rtn is -13%
2	Low stock price volatility Vol 12M is 23%

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.3%, FCF Yield is 6.0%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 16%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12%
2	Low stock price volatility Vol 12M is 23%
3	Trading close to highs Dist 52W High is -0.8%, Dist 3Y High is -0.8%
4	Weak multi-year price returns 3Y Excs Rtn is -13%
5	Weak revenue growth Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.2%

Market Valuation

	9/13/25	2024	2023	2022	2021
Share Price CYE	$184.50	$148.72	$133.06	$147.93	$160.43
Market Cap CYE ($ Bil)	20.7	16.5	14.9	16.7	19.1
Total Debt ($ Bil)	6.4	7.1	5.5	4.7	4.8
Total Cash ($ Bil)	0.3	0.5	0.7	0.3	0.9
Enterprise Value ($ Bil)	26.7	23.6	20.4	21.4	23.9
Valuation Ratios
P/S TTM	2.0	1.7	1.7	1.8	2.0
P/EBIT TTM	13.5	11.9	11.9	13.1	7.9
P/E TTM	21.8	19.2	18.1	19.2	10.8
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1	4.5	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3	-2.9
P/E TTM (Sector)	-1.9	-1.6	-1.5	-1.4	-2.9

	9/13/25	2024	2023
Share Price CYE	$184.50	$148.72	$133.06
Market Cap CYE ($ Bil)	20.7	16.5	14.9
Total Debt ($ Bil)	6.4	7.1	5.5
Total Cash ($ Bil)	0.3	0.5	0.7
Enterprise Value ($ Bil)	26.7	23.6	20.4
Valuation Ratios
P/S TTM	2.0	1.7	1.7
P/EBIT TTM	13.5	11.9	11.9
P/E TTM	21.8	19.2	18.1
Sector Ratios
P/S TTM (Sector)	3.8	3.6	4.1
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4
P/E TTM (Sector)	-1.9	-1.6	-1.5

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
DGX Return	14%	48%	-8%	-10%	12%	23%	93%
Peers Return	38%	16%	-30%	24%	21%	-7%	57%
S&P 500 Return	16%	27%	-19%	24%	23%	12%	101%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: HCA, LH, DVA, SEM, NEO. See DGX Returns vs. Peers.
[3] 2025 data is for the year up to 9/12/2025 (YTD)

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Quest Diagnostics Earnings Notes
2	Quest Diagnostics vs Southern: Which Is A Better Investment?	Counter-Intuitive Comparisons
3	Quest Diagnostics vs United Therapeutics: Which Is A Better Investment?	Counter-Intuitive Comparisons
4	How Does DGX Stack Up Against Its Peers?	Peer Comparison
5	Better Bet Than DGX Stock: Pay Less Than Quest Diagnostics To Get More From SCCO, OKE
6	Better Bet Than DGX Stock: Pay Less Than Quest Diagnostics To Get More From UTHR, HALO
7	DGX Dip Buy Analysis
8	DGX YTD Stock Return Of 18% Outperforms NEO by 71% and Underperforms HCA by -11%	Return
9	Quest Diagnostics vs. Out Of Favor Health Care Stocks: Which Is A Better Investment?	Investment Theme Comparisons
10	Quest Diagnostics Total Shareholder Return (TSR): 13.4% in 2024 and -0.6% 3-yr compounded annual returns (above peer average)
11	ARTICLES
12	Will Quest Diagnostics Stock Rebound After A Large 19% Fall In A Month?		January 19th, 2022

	Title
0	DASHBOARDS
1	Will Quest Diagnostics Stock Rebound After A Large 19% Fall In A Month?
2	ARTICLES
3	Quest Diagnostics Earnings Notes
4	Quest Diagnostics vs Southern: Which Is A Better Investment?
5	Quest Diagnostics vs United Therapeutics: Which Is A Better Investment?
6	How Does DGX Stack Up Against Its Peers?
7	Better Bet Than DGX Stock: Pay Less Than Quest Diagnostics To Get More From SCCO, OKE
8	Better Bet Than DGX Stock: Pay Less Than Quest Diagnostics To Get More From UTHR, HALO
9	DGX Dip Buy Analysis
10	DGX YTD Stock Return Of 18% Outperforms NEO by 71% and Underperforms HCA by -11%
11	Quest Diagnostics vs. Out Of Favor Health Care Stocks: Which Is A Better Investment?
12	Quest Diagnostics Total Shareholder Return (TSR): 13.4% in 2024 and -0.6% 3-yr compounded annual returns (above peer average)

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GCTK	GlucoTrack	117.5%	-97.6%
2	OPI	Office Properties Income Trust	78.6%	-42.6%
3	HCWB	HCW Biologics	68.4%	-68.7%
4	AGAE	Allied Gaming & Entertainment	62.4%	86.8%
5	ATCH	AtlasClear	53.4%	-95.9%
6	SONN	Sonnet BioTherapeutics	49.0%	304.1%
7	EVTV	Envirotech Vehicles	48.4%	-66.3%
8	ISPC	iSpecimen	47.7%	-26.6%
9	ENTO	Entero Therapeutics	37.0%	68.8%
10	IBEX	IBEX	36.5%	93.5%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	-57.4%	-93.8%
2	VCIG	VCI Global	-42.8%	-98.7%
3	RENT	Rent the Runway	-36.4%	-40.9%
4	NUAI	New Era Energy & Digital	-30.5%
5	AEI	Alset	-29.6%	156.9%
6	NAKA	Kindly MD	-29.5%
7	XTIA	XTI Aerospace	-24.6%	-85.8%
8	FARM	Farmer Bros	-21.5%	1.7%
9	FEIM	Frequency Electronics	-21.0%	46.5%
10	MSS	Maison Solutions	-20.4%	-27.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	OCTO	Eightco	900.0%	562.1%
2	QMMM	QMMM	875.3%	5698.4%
3	WLDS	Wearable Devices	780.4%	8.0%
4	CWD	CaliberCos	268.8%	-45.1%
5	AIRE	ReAlpha Tech	257.5%	-49.8%
6	PTNM	Pitanium	154.0%
7	OPI	Office Properties Income Trust	144.0%	-42.6%
8	HYPD	Hyperion DeFi	144.0%
9	ISPC	iSpecimen	128.4%	-26.6%
10	EDHL	Everbright Digital	127.6%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-85.6%
2	LGCL	Lucas GC	-69.1%	-76.6%
3	YYGH	YY	-68.7%	-76.6%
4	BINI	Bollinger Innovations	-61.6%	-100.0%
5	IPDN	Professional Diversity Network	-54.5%	-41.4%
6	INHD	Inno	-53.4%	-4.4%
7	CDT	CDT Equity	-49.2%	-99.4%
8	NFE	New Fortress Energy	-46.5%	-91.3%
9	TGHL	Growhub	-44.8%
10	SLXN	Silexion Therapeutics	-43.1%	-86.5%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	11249.2%	11249.2%
2	GIBO	GIBO	7400.0%
3	LNZA	LanzaTech Global	4710.5%	-85.8%
4	CHSN	Chanson International	3717.0%	-99.3%
5	QMMM	QMMM	2669.4%	5698.4%
6	VTAK	Catheter Precision	1332.7%	-71.4%
7	CURX	Curanex Pharmaceuticals	1309.0%	1309.0%
8	OCTO	Eightco	811.9%	562.1%
9	WLDS	Wearable Devices	708.6%	8.0%
10	PTNM	Pitanium	423.7%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	BINI	Bollinger Innovations	-93.4%	-100.0%
2	ETS	Elite Express	-92.8%	-92.8%
3	CJET	Chijet Motor	-92.7%	-94.6%
4	ELPW	Elong Power	-91.7%	-75.8%
5	STFS	Star Fashion Culture	-91.4%	-97.8%
6	JEM	707 Cayman	-90.4%	-98.0%
7	FLYE	Fly-E	-90.4%	-82.8%
8	NXTT	Next Technology	-89.3%	-93.8%
9	NUTR	NusaTrip	-87.2%	-87.2%
10	CUPR	Cuprina	-84.3%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GCTK	GlucoTrack	117.5%	-97.6%
2	OPI	Office Properties Income Trust	78.6%	-42.6%
3	HCWB	HCW Biologics	68.4%	-68.7%
4	AGAE	Allied Gaming & Entertainment	62.4%	86.8%
5	ATCH	AtlasClear	53.4%	-95.9%
6	SONN	Sonnet BioTherapeutics	49.0%	304.1%
7	EVTV	Envirotech Vehicles	48.4%	-66.3%
8	ISPC	iSpecimen	47.7%	-26.6%
9	ENTO	Entero Therapeutics	37.0%	68.8%
10	IBEX	IBEX	36.5%	93.5%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	NXTT	Next Technology	-57.4%	-93.8%
2	VCIG	VCI Global	-42.8%	-98.7%
3	RENT	Rent the Runway	-36.4%	-40.9%
4	NUAI	New Era Energy & Digital	-30.5%
5	AEI	Alset	-29.6%	156.9%
6	NAKA	Kindly MD	-29.5%
7	XTIA	XTI Aerospace	-24.6%	-85.8%
8	FARM	Farmer Bros	-21.5%	1.7%
9	FEIM	Frequency Electronics	-21.0%	46.5%
10	MSS	Maison Solutions	-20.4%	-27.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	OCTO	Eightco	900.0%	562.1%
2	QMMM	QMMM	875.3%	5698.4%
3	WLDS	Wearable Devices	780.4%	8.0%
4	CWD	CaliberCos	268.8%	-45.1%
5	AIRE	ReAlpha Tech	257.5%	-49.8%
6	PTNM	Pitanium	154.0%
7	OPI	Office Properties Income Trust	144.0%	-42.6%
8	HYPD	Hyperion DeFi	144.0%
9	ISPC	iSpecimen	128.4%	-26.6%
10	EDHL	Everbright Digital	127.6%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	DGNX	Diginex	-85.6%
2	LGCL	Lucas GC	-69.1%	-76.6%
3	YYGH	YY	-68.7%	-76.6%
4	BINI	Bollinger Innovations	-61.6%	-100.0%
5	IPDN	Professional Diversity Network	-54.5%	-41.4%
6	INHD	Inno	-53.4%	-4.4%
7	CDT	CDT Equity	-49.2%	-99.4%
8	NFE	New Fortress Energy	-46.5%	-91.3%
9	TGHL	Growhub	-44.8%
10	SLXN	Silexion Therapeutics	-43.1%	-86.5%

Peer Comparisons for Quest Diagnostics

Financials

	DGX	HCA	LH	DVA	SEM	NEO	Median
Name	Quest Di.	HCA Heal.	Labcorp	DaVita	Select M.	NeoGenom.
Mkt Price	182.91	405.13	277.95	133.17	12.51	7.96	158.04
Mkt Cap	20.5	96.9	23.2	10.1	1.5	1.0	15.3
Rev LTM	10,522	72,698	13,484	13,161	4,331	689	11,842
Op Inc LTM	1,475	11,078	1,234	1,976	116	-92	1,354
FCF LTM	1,224	7,292	1,262	1,288	182	-19	1,243
FCF 3Y Avg	992	5,704	1,084	1,305	216	-38	1,038
CFO LTM	1,678	11,935	1,694	1,862	413	14	1,686
CFO 3Y Avg	1,433	10,451	1,527	1,880	438	-7	1,480

Growth & Margins

	DGX	HCA	LH	DVA	SEM	NEO	Median
Name	Quest Di.	HCA Heal.	Labcorp	DaVita	Select M.	NeoGenom.
Rev Chg LTM	12.6%	6.4%	8.0%	5.1%	5.9%	9.7%	7.2%
Rev Chg 3Y Avg	0.2%	6.6%	4.2%	4.2%	-10.8%	12.1%	4.2%
Rev Chg Q	15.2%	6.4%	9.5%	6.1%	4.5%	10.2%	7.9%
QoQ Delta Rev Chg LTM	3.6%	1.6%	2.3%	1.5%	1.4%	2.5%	1.9%
Op Mgn LTM	14.0%	15.2%	9.2%	15.0%	2.7%	-13.4%	11.6%
Op Mgn 3Y Avg	13.3%	15.0%	9.7%	13.5%	3.7%	-16.3%	11.5%
QoQ Delta Op Mgn LTM	0.3%	0.1%	0.5%	0.0%	0.3%	-0.7%	0.2%
CFO/Rev LTM	15.9%	16.4%	12.6%	14.1%	9.5%	2.0%	13.4%
CFO/Rev 3Y Avg	14.6%	15.4%	12.1%	15.1%	10.1%	-1.4%	13.3%
FCF/Rev LTM	11.6%	10.0%	9.4%	9.8%	4.2%	-2.8%	9.6%
FCF/Rev 3Y Avg	10.1%	8.4%	8.6%	10.5%	5.0%	-6.4%	8.5%

Valuation

	DGX	HCA	LH	DVA	SEM	NEO	Median
Name	Quest Di.	HCA Heal.	Labcorp	DaVita	Select M.	NeoGenom.
Mkt Cap	20.5	96.9	23.2	10.1	1.5	1.0	15.3
P/S	1.9	1.3	1.7	0.8	0.4	1.5	1.4
P/EBIT	13.4	8.9	19.3	5.1	9.6	-10.2	9.2
P/E	21.6	16.2	30.4	12.1	11.3	-9.8	14.2
P/CFO	12.2	8.1	13.7	5.4	3.7	72.5	10.2
Total Yield	6.3%	6.9%	4.3%	8.3%	12.0%	-10.2%	6.6%
Dividend Yield	1.7%	0.7%	1.0%	0.0%	3.1%	0.0%	0.9%
FCF Yield 3Y Avg	5.8%	6.6%	5.4%	12.4%	7.0%	-2.3%	6.2%
D/E	0.3	0.5	0.3	1.3	1.9	0.4	0.4
Net D/E	0.3	0.5	0.3	1.2	1.8	0.2	0.4

Returns

	DGX	HCA	LH	DVA	SEM	NEO	Median
Name	Quest Di.	HCA Heal.	Labcorp	DaVita	Select M.	NeoGenom.
1M Rtn	2.2%	3.8%	2.2%	-1.1%	-1.3%	27.6%	2.2%
3M Rtn	2.0%	9.4%	6.7%	-2.2%	-16.5%	12.6%	4.3%
6M Rtn	8.5%	27.4%	16.7%	-7.2%	-24.7%	-19.0%	0.7%
12M Rtn	20.5%	4.3%	27.7%	-15.5%	-33.3%	-50.9%	-5.6%
3Y Rtn	54.4%	96.1%	23.9%	44.4%	-7.9%	-20.6%	34.1%
1M Excs Rtn	0.3%	1.9%	0.4%	-2.9%	-3.1%	25.7%	0.4%
3M Excs Rtn	-6.3%	0.3%	-2.4%	-12.0%	-26.2%	-1.2%	-4.4%
6M Excs Rtn	-9.9%	10.0%	-0.6%	-24.9%	-43.1%	-35.6%	-17.4%
12M Excs Rtn	2.2%	-14.1%	7.8%	-33.1%	-51.0%	-68.9%	-23.6%
3Y Excs Rtn	-12.8%	30.6%	-43.4%	-18.2%	-72.4%	-87.9%	-30.8%

Comparison Analyses

	Title
0	How Does DGX Stack Up Against Its Peers?
1	Quest Diagnostics vs. HCA: With Return Forecast Of 8.9%, Quest Diagnostics Is A Better Bet
2	With 12% Gains On The Table, LH May Outshine DGX
3	Quest Diagnostics vs. DaVita HealthCare Partners: With Return Forecast Of 5%, Quest Diagnostics Is A Better Bet
4	NEO Could Deliver 32% Returns And Outperform DGX
5	Quest Diagnostics vs. Genuine Parts: With Return Forecast Of 10%, Quest Diagnostics Is A Better Bet
6	Quest Diagnostics vs. Jacobs Engineering Group: With Return Forecast Of 21%, Jacobs Engineering Group Is A Better Bet
7	Quest Diagnostics vs. Monolithic Power Systems: With Return Forecast Of 47%, Monolithic Power Systems Is A Better Bet
8	Quest Diagnostics vs. Marriot: With Return Forecast Of 24%, Marriot Is A Better Bet
9	Quest Diagnostics vs. Vertex Pharmaceuticals: With Return Forecast Of 72%, Vertex Pharmaceuticals Is A Better Bet

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End		12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date		2/20/2025	2/22/2024	2/21/2023	2/28/2022	2/22/2021	2/20/2020
Key Financials
Total Revenue	10,522	9,872	9,252	9,883	10,788	9,437	7,726
Ebitda	2,069	1,894	1,732	1,820	3,159	2,411	1,585
Operating Income	1,475	1,346	1,262	1,428	2,381	1,971	1,231
Net Income	950	871	854	946	1,995	1,431	858
EPS	8.47	7.78	7.59	8.10	15.85	10.62	6.36
Growth Rates
Total Revenue Growth	12.6%	6.7%	-6.4%	-8.4%	14.3%	22.1%	2.6%
EBITDA Growth	18.1%	9.4%	-4.8%	-42.4%	31.0%	52.1%	12.9%
Operating Income Growth	16.7%	6.7%	-11.6%	-40.0%	20.8%	60.1%	11.8%
Net Income Growth	13.1%	2.0%	-9.7%	-52.6%	39.4%	66.8%	16.6%
Margins
EBITDA Margin	19.7%	19.2%	18.7%	18.4%	29.3%	25.5%	20.5%
Operating Income Margin	14.0%	13.6%	13.6%	14.4%	22.1%	20.9%	15.9%
Net Income Margin	9.0%	8.8%	9.2%	9.6%	18.5%	15.2%	11.1%
Cash & Debt
Total Cash	319	549	686	315	872	1,158	1,192
Total Debt	6,384	7,087	5,498	4,714	4,773	4,808	5,416
Net Debt / (Cash)	6,065	6,538	4,812	4,399	3,901	3,650	4,224
Cash Flows
Net Cash from Operations	1,678	1,334	1,272	1,718	2,233	2,005	1,243
Free Cash from Operations	1,224	909	864	1,314	1,830	1,587	843
Returns to Shareholders
Dividends	342	331	314	305	309	297	286
Share Repurchases	-0	151	275	1,408	2,199	325	353

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	7/23/2025	4/23/2025	2/20/2025	10/23/2024	7/24/2024	4/24/2024	2/22/2024	10/25/2023	7/27/2023	4/28/2023	2/21/2023	10/21/2022
Key Financials Quarterly
Total Revenue	2,761	2,652	2,621	2,488	2,397	2,366	2,288	2,295	2,338	2,331	2,333	2,486
Ebitda	596	488	506	479	478	431	392	451	468	421	261	496
Operating Income	438	346	361	330	355	300	267	342	348	305	135	392
Net Income	282	220	222	226	229	194	192	225	235	202	101	256
EPS	2.51	1.97	1.98	2.01	2.05	1.74	1.72	1.99	2.08	1.80	0.89	2.20
Key Financials TTM
Total Revenue TTM	10,522	10,158	9,872	9,539	9,346	9,287	9,252	9,297	9,488	9,603	9,883	10,294
Ebitda TTM	2,069	1,951	1,894	1,780	1,752	1,742	1,732	1,601	1,646	1,646	1,820	2,205
Operating Income TTM	1,475	1,392	1,346	1,252	1,264	1,257	1,262	1,130	1,180	1,220	1,428	1,829
Net Income TTM	950	897	871	841	840	846	854	763	794	793	946	1,235
Growth Rates Quarterly
Total Revenue Growth	15.2%	12.1%	14.6%	8.4%	2.5%	1.5%	-1.9%	-7.7%	-4.7%	-10.7%	-15.0%	-10.4%
EBITDA Growth	24.7%	13.2%	29.1%	6.2%	2.1%	2.4%	50.2%	-9.1%	0.0%	-29.2%	-59.6%	-37.5%
Operating Income Growth	23.4%	15.3%	35.2%	-3.5%	2.0%	-1.6%	97.8%	-12.8%	-10.3%	-40.5%	-74.8%	-39.9%
Net Income Growth	23.1%	13.4%	15.6%	0.4%	-2.6%	-4.0%	90.1%	-12.1%	0.4%	-43.1%	-74.1%	-49.3%
Margins Quarterly
EBITDA Margin	21.6%	18.4%	19.3%	19.3%	19.9%	18.2%	17.1%	19.7%	20.0%	18.1%	11.2%	20.0%
Operating Income Margin	15.9%	13.0%	13.8%	13.3%	14.8%	12.7%	11.7%	14.9%	14.9%	13.1%	5.8%	15.8%
Net Income Margin	10.2%	8.3%	8.5%	9.1%	9.6%	8.2%	8.4%	9.8%	10.1%	8.7%	4.3%	10.3%
Cash & Debt
Total Cash	319	188	549	764	271	474	686	143	126	175	315	700
Total Debt	6,384	6,570	7,087	6,970	5,088	5,352	5,498	4,912	4,959	4,622	4,714	4,640
Net Debt / (Cash)	6,065	6,382	6,538	6,206	4,817	4,878	4,812	4,769	4,833	4,447	4,399	3,940
Cash Flows Quarterly
FCF from Operations	544	314	464	356	360	154	527	207	444	94	334	502
Cash Flows TTM
FCF from Operations TTM	1,678	1,494	1,334	1,397	1,248	1,332	1,272	1,079	1,374	1,332	1,718	1,865
Returns to Shareholders Quarterly
Dividends	90	84	84	84	84	79	80	80	80	74	75	78
Share Repurchases	-0	-0	-0	-0	-0	-0	275	-0	-0	-0	461	374
Return on Invested Capital (ROIC) Quarterly
ROIC	21.6%	17.1%	17.1%	16.6%	22.5%	18.5%	18.4%	22.2%	22.0%	21.0%	12.3%	30.6%
Return on Invested Capital (ROIC) TTM
ROIC TTM	18.7%	16.9%	15.8%	15.7%	20.4%	20.0%	20.5%	18.9%	19.4%	21.8%	25.5%	35.5%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Diagnostic Information Services (DIS) Business	8,976	9,609	10,494	9,139	7,405
Diagnostic Solutions (DS) group	276	274
All other operating segments			294	298	321
Total	9,252	9,883	10,788	9,437	7,726

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
Diagnostic Information Services (DIS) Business	1,547	1,704	2,646	2,201	1,298
Diagnostic Solutions (DS) group	34	20
General corporate activities	-319	-296	-294	-269	-109
All other operating segments			29	39	42
Total	1,262	1,428	2,381	1,971	1,231

Price Behavior

Behavior Stats
Betas Matrix

Price Behavior

Market Price	$182.91
Market Cap ($ Bil)	20.5
First Trading Date	12/26/1996
Distance from 52W High	-0.8%
	50 Days	200 Days
DMA Price	$175.57	$168.13
DMA Trend	up	up
Distance from DMA	4.2%	8.8%
	3M	1YR
Volatility	23.1%	22.8%
Downside Capture	0.03	0.18
Upside Capture	14.31	37.81
Correlation (SPY)	-8.9%	23.7%

DGX Betas & Captures as of 8/31/2025

	1M	2M	3M	6M	1Y	3Y
Beta	-0.57	-0.65	-0.27	0.27	0.27	0.36
Up Beta	-0.19	-1.12	-0.78	0.27	0.25	0.41
Down Beta	-1.21	-1.46	-0.81	0.23	0.27	0.31
Up Capture	10%	-4%	20%	26%	26%	12%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	13	22	35	67	132	388
Down Capture	-160%	-31%	-8%	32%	32%	58%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	8	20	28	59	115	361

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	8292025
Short Interest: Shares Quantity	4,249,168
Short Interest: % Change Since 8152025	5.4%
Average Daily Volume	825,984
Days-to-Cover Short Interest	5.14
Basic Shares Quantity	112,000,000
Short % of Basic Shares	3.8%

Returns Analyses

	Title
0	DGX YTD Stock Return Of 18% Outperforms NEO by 71% and Underperforms HCA by -11%
1	Will You Be Comfortable Buying Quest Diagnostics Stock?
2	DGX YTD Stock Return Of -21% Outperforms NEO by 49% and Underperforms LH by -4.5%
3	Quest Diagnostics Stock Return Comparison
4	[10/6/2021] Quest Diagnostics (DGX) Stock Price Forecast: AI Forecasts DGX Stock Price To Be Around $148 In A Month (Up 3.9%)
5	Quest Diagnostics Total Shareholder Return (TSR): -8.1% in 2022 and 15.4% 3-yr returns (above peer average)

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
7/22/2025	7.1%	0.8%	9.8%
4/22/2025	6.8%	9.2%	10.1%
1/30/2025	5.6%	6.1%	11.2%
10/22/2024	6.9%	5.8%	9.4%
7/23/2024	-4.3%	-3.5%	2.4%
4/23/2024	5.1%	7.2%	10.2%
2/1/2024	-1.0%	-0.8%	-2.9%
10/24/2023	1.8%	6.6%	10.6%
...
SUMMARY STATS
# Positive	14	13	16
# Negative	10	11	8
Median Positive	4.0%	6.1%	9.6%
Median Negative	-3.0%	-2.0%	-6.2%
Max Positive	7.1%	18.5%	20.6%
Max Negative	-6.8%	-11.6%	-14.9%

	Forward Returns
7/22/2025	7.1%	0.8%	9.8%
4/22/2025	6.8%	9.2%	10.1%
1/30/2025	5.6%	6.1%	11.2%
10/22/2024	6.9%	5.8%	9.4%
7/23/2024	-4.3%	-3.5%	2.4%
4/23/2024	5.1%	7.2%	10.2%
2/1/2024	-1.0%	-0.8%	-2.9%
10/24/2023	1.8%	6.6%	10.6%
7/26/2023	-6.0%	-7.1%	-7.9%
4/27/2023	-4.0%	-7.0%	-9.6%
2/2/2023	-2.1%	-1.6%	-5.3%
10/20/2022	6.3%	13.3%	15.2%
7/21/2022	-0.2%	-0.4%	0.8%
4/21/2022	2.3%	-0.7%	1.2%
1/12/2022	-6.8%	-11.6%	-14.9%
10/21/2021	-1.0%	-2.0%	0.7%
7/22/2021	1.6%	3.1%	11.7%
4/22/2021	2.8%	1.3%	1.1%
2/4/2021	-3.9%	-2.6%	-7.0%
10/22/2020	2.9%	1.7%	-0.0%
7/13/2020	2.0%	7.1%	3.8%
4/22/2020	5.4%	18.5%	20.6%
1/30/2020	1.2%	1.2%	-4.2%
10/22/2019	-1.5%	-1.8%	2.2%
SUMMARY STATS
# Positive	14	13	16
# Negative	10	11	8
Median Positive	4.0%	6.1%	9.6%
Median Negative	-3.0%	-2.0%	-6.2%
Max Positive	7.1%	18.5%	20.6%
Max Negative	-6.8%	-11.6%	-14.9%

SEC Filings

Expand for More

Report Date	Filing
6302025	10-Q 6/30/2025
3312025	10-Q 3/31/2025
12312024	10-K 12/31/2024
9302024	10-Q 9/30/2024
6302024	10-Q 6/30/2024
3312024	10-Q 3/31/2024
12312023	10-K 12/31/2023
9302023	10-Q 9/30/2023
6302023	10-Q 6/30/2023
3312023	10-Q 3/31/2023
12312022	10-K 12/31/2022
9302022	10-Q 9/30/2022
6302022	10-Q 6/30/2022
3312022	10-Q 3/31/2022
12312021	10-K 12/31/2021
9302021	10-Q 9/30/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Plewman Patrick	SVP for Diagnostic Services	8252025	Sell	185.00	1,975	365,375	2,824,765	Form
1	Plewman Patrick	SVP for Diagnostic Services	8192025	Sell	180.00	1,975	355,500	3,103,920	Form
2	DELANEY MARK E	SVP & Chief Commercial Officer	5142025	Sell	175.72	874	153,579	1,471,128	Form
3	Davis J. E.	CEO and President	4042025	Sell	168.03	2,366	397,553	27,631,786	Form
4	KUPPUSAMY KARTHIK	SVP, Clinical Solutions	4042025	Sell	170.00	2,555	434,350	1,797,750	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Quest Diagnostics (DGX)

Market Price (9/13/2025): $184.5 | Market Cap: $20.7 BilSector: Health Care | Industry: Health Care Services

Quest Diagnostics (DGX)

Market Price (9/13/2025): $184.5Market Cap: $20.7 BilSector: Health CareIndustry: Health Care Services

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Quest Diagnostics (DGX)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Quest Diagnostics

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/13/2025): $184.5 | Market Cap: $20.7 Bil
Sector: Health Care | Industry: Health Care Services

Market Price (9/13/2025): $184.5
Market Cap: $20.7 Bil
Sector: Health Care
Industry: Health Care Services